CHRISTINE THUMMA: Open Payments
NPI 1437695160 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,444 in 92 payments from 19 companies in 2025. Trend: 2023 $1,955 · 2024 $1,513 · 2025 $1,444
Food & beverage: $1,444
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $355 |
| Otsuka America Pharmaceutical, Inc. | 16 | $182 |
| Alkermes, Inc. | 10 | $165 |
| Teva Pharmaceuticals USA, Inc. | 5 | $101 |
| Axsome Therapeutics, Inc. | 4 | $97 |
| Indivior Inc. | 4 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 4 | $64 |
| Corium, LLC | 3 | $49 |
| Noven Therapeutics, LLC | 2 | $39 |
Products named: VRAYLAR, ARISTADA, Auvelity, SUBLOCADE, REXULTI, CAPLYTA, MAVYRET, AUSTEDO XR.
Industry payments across TN — which companies pay providers there.
